Home › Nivalis Therapeutics A No-Brainer For Biotech Investors
 

Keywords :   


Nivalis Therapeutics A No-Brainer For Biotech Investors

2015-06-15 22:09:24| Biotech - Topix.net

Nivalis Therapeutics is a mid-clinical trial stage pharmaceutical company working with therapies that target certain gene mutations in cystic fibrosis patients. The company is preparing for its initial public offering to raise funds for continuing clinical trials and research.

Tags: investors biotech therapeutics nobrainer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »